A delegation led by the Association of Indian Medical Device Industry (AIMED) recently traveled to the United Kingdom for a high-level roundtable in the UK Parliament, with the goal of tripling India’s medical device exports by 2030.
Currently, Indian medtech exports to the UK stand at roughly GBP 96 million (2024), and AIMED aims to raise this to GBP 250–300 million by the end of the decade.
Key discussion points during the delegation’s meetings included regulatory alignment  particularly mutual recognition of regulatory approvals  market access, and technology transfer. Indian manufacturers are pushing for UK recognition of products approved by India’s CDSCO (or ICMED certification) to speed up product entry.
They also emphasized building joint manufacturing and R&D partnerships to foster innovation and reduce costs.
Voice Of HealthCare

The trade opportunity is further supported by India–UK tariff concessions: under the new free trade agreement, many medtech products will benefit from lower or zero duties.
This could make Indian medical devices more competitive in the UK, particularly in high-volume product categories like surgical instruments, diagnostic reagents, and disposables.

However, industry voices remain cautious. Several medtech firms have flagged concerns over rules of origin  fearing that third-country products routed via the UK under preferential tariffs could undermine genuine Indian exports.
AIMED and other stakeholders are calling for strict verification to avoid misuse of the trade deal.